Full FDA approval of a drug is a significant milestone for pharmaceutical companies, often leading to increased investor confidence and a positive impact on the company's stock price. As the approval of TARPEYO is a major achievement for Calliditas Therapeutics, it is likely to result in increased investor interest and a potential rise in stock price in the short term.